SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
CERS Cerus Corporation
An SI Board Since November 2014
Posts SubjectMarks Bans Symbol
12 1 0 CERS
Emcee:  Savant Type:  Moderated
Introduction Market Data Compact
CERS Cerus Corporation is a biomedical products company focused in the field of blood safety.Cerus currently markets and sells the INTERCEPT Blood System for both platelets and plasma in Europe, the Commonwealth of Independent States, the Middle East and selected countries in other regions around the world. In the United States, Cerus is seeking regulatory approval of the INTERCEPT Blood System for plasma and platelets. The INTERCEPT red blood cell system is in clinical development. See cts.businesswire.com for more information.

INTERCEPT and the INTERCEPT Blood System are trademarks of Cerus Corporation.

Platelet photo-Props to.. sciencephoto.com
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
12Cerus and Unyts Enter Into Agreement for the Use of INTERCEPT Platelets and PlasSavant-7/21/2015
11 Cerus to Present at AABB Symposium on Pathogen-Reduced Components COSavant-4/27/2015
10 Cerus soars after article calls for blood screensShares of CeSavant-4/27/2015
9 Cerus and SunCoast Blood Bank Enter Into Agreement for the Use of Savant-2/5/2015
8CERS..Came out AFTER Afmar closed... FDA Approves INTERCEPT BlSavant-12/20/2014
7Soooo, CERS hit 7.50 in the afmar...Savant-12/18/2014
6 Finally!....Cerus confirms FDA approval of INTERCEPT Blood System foSavant-12/16/2014
5FDA approval for Cerus' Intercept Hit $6.42 in aftermarket...no shares availSavant-12/16/2014
4 FDA Accepts IDE Supplement for INTERCEPT Blood System Treatment of ESavant-11/21/2014
3CERS use in Ebola cases... "A plasma recipient must have a compatible blooSavant-11/20/2014
2Platelets ouhsc.eduSavant-11/20/2014
1Recent Highlights Signed agreement with Kawasumi Laboratories to develop an INTSavant-11/20/2014
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News